N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141747 |
| CAS No | NA |
| Mol.F. | C12H16N6O5 |
| Mol.Wt. | 324.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141748 |
| CAS No | NA |
| Mol.F. | C24H39N3O6 |
| Mol.Wt. | 465.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141749 |
| CAS No | NA |
| Mol.F. | C25H41N3O6 |
| Mol.Wt. | 479.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141750 |
| CAS No | NA |
| Mol.F. | C15H23N7O6 |
| Mol.Wt. | 397.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141751 |
| CAS No | NA |
| Mol.F. | C24H39N3O6 |
| Mol.Wt. | 465.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141752 |
| CAS No | NA |
| Mol.F. | C29H43N13O11 |
| Mol.Wt. | 749.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141753 |
| CAS No | 155386-25-7 |
| Mol.F. | C66H74Cl2N10O25 |
| Mol.Wt. | 1478.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141754 |
| CAS No | NA |
| Mol.F. | C21H21BrFN5O3 |
| Mol.Wt. | 490.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141755 |
| CAS No | NA |
| Mol.F. | C17H17FN2O4 |
| Mol.Wt. | 332.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141756 |
| CAS No | NA |
| Mol.F. | C24H23F2N3O3 |
| Mol.Wt. | 439.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141757 |
| CAS No | NA |
| Mol.F. | C17H18FN3O3 |
| Mol.Wt. | 331.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141758 |
| CAS No | NA |
| Mol.F. | C23H21F2N3O3 |
| Mol.Wt. | 425.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141759 |
| CAS No | NA |
| Mol.F. | C17H18FN3O3 |
| Mol.Wt. | 331.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141760 |
| CAS No | NA |
| Mol.F. | C18H19FN2O4 |
| Mol.Wt. | 346.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141761 |
| CAS No | NA |
| Mol.F. | C17H18FN3O3 |
| Mol.Wt. | 331.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141762 |
| CAS No | 24642-83-9 |
| Mol.F. | C9H12N2O |
| Mol.Wt. | 164.2 |
| INV STATUS | CUSTOM SYNTHESIS |